The DOI matches its Crossref record; 213 of the 214 references it cites were found in a registry or an index.
Schizophrenia--Time to Commit to Policy Change
Open accessAbstract
Care and outcomes for people with schizophrenia have improved in recent years, but further progress is needed to help more individuals achieve an independent and fulfilled life. This report sets out the current need, informs policy makers and all relevant stakeholders who influence care quality, and supports their commitment to creating a better future. The authors recommend the following policy actions, based on research evidence, stakeholder consultation, and examples of best practice worldwide. (1) Provide an evidence-based, integrated care package for people with schizophrenia that addresses their mental and physical health needs. (2) Provide support for people with schizophrenia to enter and to remain in their community, and develop mechanisms to help guide them through the complex benefit and employment systems. (3) Provide concrete support, information, and educational programs to families and carers on how to enhance care for an individual living with schizophrenia in a manner that entails minimal disruption to their lives. (4) All stakeholders, including organizations that support people living with schizophrenia, should be consulted to regularly revise, update, and improve policy on the management of schizophrenia. (5) Provide support, which is proportionate to the impact of the disease, for research and development of new treatments. (6) Establish adequately funded, ongoing, and regular awareness-raising campaigns that form an integral part of routine plans of action. Implementation of the above recommendations will require engagement by every stakeholder, but with commitment from all, change can be achieved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, empirical evidence is still limited, and additional studies are welcomed [15].”
From Mindfulness-based social cognition training (SocialMIND) versus psychoeducational multicomponent intervention for people with a first episode of psychosis: A study protocol for a randomised controlled trial (2019) · cites this paper as [15]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia
Jones, C. A., Hacker, D., Meaden, A., Cormac, I., & Irving, C. B. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000524.pub3 · Cited by 97
RetractedJournal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,703
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
(1996) · Cited by 6,884
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033430 · Cited by 2,999
Current Cigarette Smoking Among Adults — United States, 2005–2014
Jamal, A., Homa, D. M., O’Connor, E., Babb, S. D., Caraballo, R. S., Singh, T., Hu, S., & King, B. A. (2015) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6444a2 · Cited by 2,544
Flagged first, then by citations
1 of the 214 references couldn’t be matched to a known paper.
Research works printed but not linked: 16
- Leucht, 2012, Cochrane database of systematic reviews (Online), 5, CD008016
- 2013, 9, 787
- Connock, 2006, Health technology assessment (Winchester, England), 10, iii
- Lieberman, 2008, Psychiatric Services, 59, 487, 10.1176/appi.ps.59.5.487 · DOI
- Davis, 1985, The Journal of clinical psychiatry, 46, 18
- Jones, 2012, Cochrane database of systematic reviews (Online), 4, CD008712
- 2003, Cochrane database of systematic reviews (Online), 4, CD000088
- 1996, International clinical psychopharmacology, 11, 77
- Dixon, 2011, Psychiatric Services, 62, 591, 10.1176/appi.ps.62.6.591 · DOI
- 1997, Social policy, 27, 27
- Sullivan, 2006, Psychiatric Services, 57, 1126, 10.1176/appi.ps.57.8.1126 · DOI
- 2006, Cochrane database of systematic reviews (Online), 4, CD000453
- Herman, 2011, Psychiatric Services, 62, 713, 10.1176/appi.ps.62.7.713 · DOI
- 2013, The journal of mental health policy and economics, 16, 81
- Ryan, 2010, Psychiatric Services, 61, 469, 10.1176/appi.ps.61.5.469 · DOI
- Cougnard, 2007, Psychiatric Services, 58, 1427, 10.1176/appi.ps.58.11.1427 · DOI
Cited by
Sorted by citations
Items 101–200 of 215
Shoham, N., Hayes, J., Cooper, C., Theodorsson, M., & Lewis, G. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab121 · Cited by 8
Vine, R., Turner, S., Pirkis, J., Judd, F. K., & Spittal, M. J. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415599847 · Cited by 8
Réflexion sur la péréquation financière de psychiatrie en France
Boyer, L., Fond, G. B., Devictor, B., Samuelian, J., Lançon, C., Rouillon, F., Raphaël Gaillard, B., Zendjidjian, X. Y., & Llorca, P. (2016) · L Encéphale · doi:10.1016/j.encep.2016.03.014 · Cited by 8
Onwumere, J., Bonetto, C., Lasalvia, A., Miglietta, E., Veronese, A., Bellini, F., Imbesi, M., Bebbington, P., Kuipers, E., Ruggeri, M., et al. (2019) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796019000155 · Cited by 8
Mediavilla, R., Muñoz-Sanjosé, A., Rodríguez-Vega, B., Bayon, C., Lahera, G., Palao, Á., & Bravo-Ortiz, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00299 · Cited by 8
Li, Y., Sun, E., Dai, R., Chen, J., Huang, H., Shan, X., & Li, Y. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06411-w · Cited by 7
An Integrated Account of Expert Perspectives on Functioning in Schizophrenia
Nuño, L., Guilera, G., Rojo, E., Gómez‐Benito, J., & Barrios, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184223 · Cited by 7
Sabra, M. A. A., Hamaideh, S. H., & Hamdan‐Mansour, A. M. (2022) · Issues in Mental Health Nursing · doi:10.1080/01612840.2022.2025634 · Cited by 9
Viganò, C. A., Ariu, C., Barbieri, D., Goffredi, A., Ferrara, L., Rea, F., Barlati, S., Vita, A., & SIRP Survey Group (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1130811 · Cited by 7
The potential of induced pluripotent stem cells for discriminating neurodevelopmental disorders
Breitmeyer, R., Jeckel, P., Kraushaar, U., Wüst, R., Fallgatter, A. J., & Volkmer, H. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0206 · Cited by 6
Unveiling the role of Na⁺/K⁺-ATPase pump: neurodegenerative mechanisms and therapeutic horizons
Sidhu, R. K., Maparu, K., Singh, S., & Aran, K. R. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00717-6 · Cited by 8
Zhang, L., Wu, T., Li, J., Du, C., Chi, R., Jiang, K., Qiu, H., Hsu, Y., Dong, W., Wang, H., et al. (2025) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253251360400 · Cited by 6
Shoham, N., Dunca, D., Cooper, C., Hayes, J., McQuillin, A., Bass, N. J., Lewis, G., & Kuchenbaecker, K. B. (2023) · BJPsych Open · doi:10.1192/bjo.2023.6 · Cited by 6
Lee, Y.-W., Chen, T., Hsu, C., Chen, M., Lin, P., Huang, Y., Hung, C., & Chen, C.-R. (2024) · Healthcare · doi:10.3390/healthcare12212104 · Cited by 6
Hoertnagl, C. M., Kaufmann, A., Yalcin-Siedentopf, N., Pfaffenberger, N. M., Frajo-Apor, B., Pardeller, S., Kemmler, G., & Hofer, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.570857 · Cited by 6
Shakeri, A., Chu, C., Stamenova, V., Fang, J., Barker, L. C., Vigod, S. N., Bhatia, R. S., & Tadrous, M. (2022) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgac046 · Cited by 6
Mediavilla, R., Muñoz-Sanjose, A., Rodriguez-Vega, B., Bayon, C., Palao, A., Lahera, G., Sanchez-Castro, P., Roman, E., Cebolla, S., de Diego, A., et al. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2206-4 · Cited by 5
Pomgulated methionil (LY2140023) in schizophrenia patients: a systematic review and meta-analysis
AbouShawareb, H., Abbas, O., Ghabour, H., Hassan, O., Shelbaya, A. N., Abdelsalam, R., & Meshref, M. M. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07199-z · Cited by 5
Yu, S.-C., Hwang, T., Liu, C., Chan, H., Kuo, C., Yang, T., Wang, J.-P., Liu, C., Hsieh, M. H., Lin, Y., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05598-2 · Cited by 5
Percudani, M., Iardino, R., Porcellana, M., Lisoni, J., Brogonzoli, L., Barlati, S., & Vita, A. (2023) · Brain Sciences · doi:10.3390/brainsci13050822 · Cited by 5
Hassib, L., Kanashiro, A., Pedrazzi, J. F. C., Vercesi, B. F., Higa, S., Arruda, Í., Soares, Y., de Souza, A. P., Jordão, A. A., Guimarães, F. S., et al. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100923 · Cited by 6
Real-life functioning and duration of illness in schizophrenia: A mediation analysis
Brasso, C., Bellino, S., Bozzatello, P., Montemagni, C., & Rocca, P. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e41332 · Cited by 7
Edlinger, M., Rettenbacher, M. A., Kemmler, G., Biedermann, F., Widschwendter, C. G., Fleischhacker, W. W., & Hofer, A. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000573 · Cited by 5
Self-citationMisidentification of Acute Psychiatric Symptoms in the Emergency Room: Clinical Experience in China
Liu, F., Chen, J., Du, Y., Jiang, W., Gong, L., & Mu, J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.579484 · Cited by 5
The impact of creativity on functional outcome in schizophrenia: a mediational model
Sampedro, A., Peña, J., Sánchez, P., Ibarretxe‐Bilbao, N., Iriarte‐Yoller, N., Pavón, C., Hervella, I., Tous‐Espelosin, M., & Ojeda, N. (2021) · Schizophrenia · doi:10.1038/s41537-021-00144-5 · Cited by 5
Lecomte, T., Addington, J., Bowie, C., Lepage, M., Potvin, S., Shah, J. L., Summerville, C., & Tibbo, P. G. (2021) · The Canadian Journal of Psychiatry · doi:10.1177/07067437211009122 · Cited by 5
Durgam, S., Earley, W. R., Li, R., Li, D., Lu, K., Laszlovszky, I., Wolfgang Fleischhacker, W., & Nasrallah, H. A. (2020) · Ukrains kyi Visnyk Psykhonevrolohii · doi:10.36927/2079-0325-v28-is3-2020-5 · Cited by 5
Русаковская, О. А., Харитонова, Н. К., Movina, L. G., & Papsuev, O. O. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1120141 · Cited by 5
Jeleč, V., Bajić, Ž., Filipčić, I. Š., Pajić, I. P., Knežević, M. Š., Miloloža, I., Radić-Krišto, D., Benjak, T., Jakšić, N., Šagud, M., et al. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2190-8 · Cited by 4
Li, Y.-H., Huang, W., Xiao, M.-Y., Huang, S.-Q., Chen, H., Li, Z.-F., Li, X.-S., & Cheng, Y. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s355985 · Cited by 4
Chen, L., Sun, L., Luo, B., Yu, H., Li, W., Yang, Y., & Liu, H. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05375-7 · Cited by 4
Ali, M. P., Tiles-Sar, N., Simons, C. J. P., Osicka, D. A., Habtewold, T. D., van der Meer, L., Bruggeman, R., & Alizadeh, B. Z. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.10.011 · Cited by 4
Differential Expression of miR-26b-5p, EGR1, and STAT1 in Peripheral Blood of Schizophrenia Patients
Liu, Y., Qin, F., Yu, L., Zhao, X., Long, Q., Ma, X., You, X., Zhang, Y., Chen, Y., & Zeng, Y. (2024) · Psychiatry and Clinical Psychopharmacology · doi:10.5152/pcp.2024.24882 · Cited by 4
Fan, X., Zhao, X., Zhu, B., & Qin, H. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00215 · Cited by 4
Sharma, P., Riehm, K. E., Young, A. S., Reynolds, M., Tarter, R. E., Horner, M. S., & Hammond, C. J. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.1964086 · Cited by 4
Masinga, N., Nyamaruze, P., & Akintola, O. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04276-5 · Cited by 5
Kaewwanna, W., Bhatarasakoon, P., & Kitsumban, V. (2023) · Pacific Rim International Journal of Nursing Research · doi:10.60099/prijnr.2023.262390 · Cited by 4
Wavelet Based and Statistical EEG Analysis in Patients with Schizophrenia
Yılmaz, M. (2021) · Traitement du signal · doi:10.18280/ts.380523 · Cited by 4
Hsu, Y.-C., Hung, T.-Y., Chen, Y. B., Hung, K., Liang, C., Tseng, P., Tu, Y., Correll, C. U., Hsu, C., & Solmi, M. (2025) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaf059 · Cited by 3
G6PD deficiency in brain induces schizophrenia-like behaviors and synaptic dysfunction
Wang, Y.-B., Xie, P.-X., Mei, W.-Y., Yong, Y.-Y., Yu, X., Hu, L., Chen, J., Sun, Y., Zhao, X., Song, N., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03631-w · Cited by 3
Kaewwanna, W., Bhatarasakoon, P., & Kitsumban, V. (2023) · JBI Evidence Synthesis · doi:10.11124/jbies-22-00132 · Cited by 3
Changes in well-being of schizophrenic patients after movement therapy
Pohlmann, V., Koch, S. C., & Fuchs, T. (2017) · Routledge eBooks · doi:10.4324/9781315616636-7 · Cited by 3
Sun, Y., Wang, M., Yu, H., Su, H., & Zhou, Y. (2022) · Psychology Health & Medicine · doi:10.1080/13548506.2022.2124294 · Cited by 3
Budget impact of introducing once-every-6-months paliperidone palmitate in US health care plans
Phelps, H., Lin, D., Keenan, A., Raju, A., Huang, D., Cheng, C.-Y., & Benson, C. J. (2023) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2023.29.3.303 · Cited by 5
Relación entre empleo y bienestar emocional en personas con trastorno mental grave
Finol, O., Perdigón, A. L., López, V., Carralón, S., & Fraguas, D. (2021) · Revista de la Asociación Española de Neuropsiquiatría · doi:10.4321/s0211-57352021000200006 · Cited by 3
Nibbio, G., Calzavara‐Pinton, I., Barlati, S., Stanga, V., Bertoni, L., Necchini, N., Zardini, D., Lisoni, J., Deste, G., & Vita, A. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.06.023 · Cited by 3
Sood, M., Chadda, R. K., Singh, P., Chawla, N., Patel, R., Patil, V., Padmavati, R., THARA, R., Mohan, M., Iyer, S. N., et al. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104120 · Cited by 3
Racial and ethnic differences in comorbid psychosis: a population-based study
Sankoh, M., Clifford, J. S., Peterson, R. E., & Prom‐Wormley, E. C. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1280253 · Cited by 3
Zhang, X., Zhang, K., Liu, K.-J., Yu, S., Fu, X., Yuan, Q., Zhu, C., Lin, D., & Fan, Z. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117845 · Cited by 3
de Ataíde, B. R. B., Carvalho, G. A., & Guterres, A. D. S. (2022) · Research Society and Development · doi:10.33448/rsd-v11i7.29895 · Cited by 3
Song, J., Xin, W., Yu, J., Zhao, Q., Li, H.-N., & Chen, D.-C. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1514475 · Cited by 2
Rashid, M. H., Tran, N. H., Babu, D., Lockhart, S., Eldalal, O., Tran, P., Reiz, B., & Siraki, A. G. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111581 · Cited by 2
Psychosocial Recovery-Oriented Interventions in Schizophrenia
Barlati, S., Regina, V., Deste, G., Galluzzo, A., Turrina, C., Valsecchi, P., & Vita, A. (2022) · Comprehensive approach to psychiatry · doi:10.1007/978-3-030-98301-7_6 · Cited by 2
CD73 polymorphisms are associated with schizophrenia
Peng, H.-X., Zhang, L.-L., Jiang, D., Jian, N., Zhang, T.-M., Luo, J.-G., & Yin, H.-Y. (2024) · Purinergic Signalling · doi:10.1007/s11302-024-10004-3 · Cited by 2
Innovative technologies for mental healthcare: An application for severely mentally ill persons
Fitapelli, B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18529-8.00074-3 · Cited by 2
Hune, N. D., Kimball, T. G., Shumway, S. T., Webb, J. R., & Harris, K. S. (2024) · Alcoholism Treatment Quarterly · doi:10.1080/07347324.2024.2435367 · Cited by 2
Roach, M., Lin, D., Graf, M., Pednekar, P. P., Chou, J. W., Benson, C. J., & Doshi, J. A. (2021) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2021.27.10-aa.s2 · Cited by 2
Horikoshi, S., Miura, I., Mui, A., Hikichi, T., Aono, T., Hoshino, K.-Y., Terayama, K., & Yabe, H. (2022) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001599 · Cited by 2
Schizophrenia and substance abuse
DeLisi, L. E., & Fleischhacker, W. W. (2017) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000328 · Cited by 2
Self-citationÇetin, N., & Aylaz, R. (2020) · Perspectives In Psychiatric Care · doi:10.1111/ppc.12531 · Cited by 3
Integrierte Neurokognitive Therapie INT für schizophren Erkrankte
Müller, D., & Roder, V. (2020) · Psychotherapie · doi:10.30820/2364-1517-2020-1-55 · Cited by 2
The NRF1/miR-4514/SOCS3 Pathway Is Associated with Schizophrenia Pathogenesis
Liu, Y., Li, S., Ma, X., Long, Q., Yu, L., Chen, Y., Wu, W., Guo, Z., Teng, Z., & Zeng, Y. (2021) · Clinical Neurology and Neuroscience · doi:10.11648/j.cnn.20210504.13 · Cited by 2
Khdour, M. R., & Salman, A. (2022) · Journal of Pharmaceutical Health Services Research · doi:10.1093/jphsr/rmac019 · Cited by 1
Identification of VIPR2 rare and common variants in the Chinese Han population with schizophrenia
Yin, J., Zhou, J., Fang, F., Yu, S., Wang, J., Yuan, J., & Zhou, Z. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1170708 · Cited by 1
The kynurenine pathway of tryptophan catabolism and schizophrenia
Marković, M., Nikolić, T., & Totić-Poznanović, S. (2023) · Medicinski podmladak · doi:10.5937/mp74-40330 · Cited by 1
Second-generation antipsychotic drugs and their impact on adipose tissue
Rada, P., Ferreira, V., & Valverde, Á. M. (2024) · Anales de la Real Academia Nacional de Farmacia · doi:10.53519/analesranf.2024.90.01.02 · Cited by 1
Association between the copy number variations of Methyl-CpG binding domain family and schizophrenia
Sun, Z., Kou, C., Gao, Z., Guo, X., Han, B., Feng, Y., Ding, Q., & Bai, W. (2024) · Gene · doi:10.1016/j.gene.2024.148836 · Cited by 1
Cheng, K.-Y., Wang, Y., Hung, W.-C., & Yen, C.-F. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06849-6 · Cited by 1
Dufour, I., Legault, V., Brou, S. E., Brodeur, S., Courteau, J., & Chiu, Y. M. (2025) · The Canadian Journal of Psychiatry · doi:10.1177/07067437251387542 · Cited by 1
Yu, S., Zhang, Q., Feng, Y., & Guan, X.-B. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1767219 · Cited by 1
Liu, Y., Fan, X., Yu, J., Tong, S., Sun, Y., Lei, P., Wang, L., Jia, M., Ma, X., Qiao, L., et al. (2026) · Journal of Environmental Sciences · doi:10.1016/j.jes.2026.03.082 · Cited by 1
Amorim, L., Neto, L. F., Archer, A. B., Frainer, J., & Cruz, R. M. (2017) · Revista Avaliação Psicológica · doi:10.15689/ap.2017.1604.13050 · Cited by 1
Public policy and service needs in mental health
Knapp, M. R. J. (2020) · doi:10.1093/med/9780198713005.003.0134 · Cited by 1
Self-citationAnh, T. T., Anh, M. T. L., & Cường, L. V. (2021) · THE BANGKOK MEDICAL JOURNAL · doi:10.31524/bkkmedj.2021.21.003 · Cited by 1
Internações por transtornos mentais e comportamentais em Minas Gerais
Ribeiro, C. C. F., Gonçalves, A. M. S., Araújo, A. A., Nunes, E. D., Silva, J. M. A., de Albuquerque, L. N., & de Prince, K. A. (2022) · Research Society and Development · doi:10.33448/rsd-v11i15.36832 · Cited by 1
Integrating Multi-scale Feature Representation and Ensemble Learning for Schizophrenia Diagnosis
Xiao, M., Kuang, H., Liu, J., Zhang, Y., Xiang, Y., & Wang, J. (2022) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm55620.2022.9994950 · Cited by 1
Complex medical conditions and health risk behaviors among homeless males with schizophrenia
Rojanaworarit, C., Songsiripradubboon, S., Worahan, V., Kerdpon, P., & Photisan, N. (2025) · Narra J · doi:10.52225/narra.v5i1.1194 · Cited by 2
Gou, L., Su, R.-C., Guo, R., Li, L., Li, J., Zhou, B., Huang, L., & Li, H. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06646-1 · Cited by 1
Lin, C.-C., Chuang, C.-C., Wang, C., & Cheng, S. (2025) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf206 · Cited by 1
Severe Mental Disorders and Neuropsychiatric Conditions in Refugee Children and Adolescents
Liu, N. H., & Chowdhary, N. (2020) · Springer eBooks · doi:10.1007/978-3-030-45278-0_13 · Cited by 1
Roach, M., Lin, D., Graf, M., Pednekar, P. P., Chou, J. W., Benson, C. J., & Doshi, J. A. (2021) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2021.27.10-a.s1 · Cited by 1
Almulla, A. F., Moustafa, S. R., Al-Dujaili, A. H., Al‐Hakeim, H. K., & Maes, M. H. J. (2020) · Preprints.org · doi:10.20944/preprints202002.0175.v1 · Cited by 1
Development and validation of polygenic risk profiles of schizophreniaPreprint
Kocak, E., Naamanka, J., Gradinger, T., Klaassen, F., Nitsche, J., Grotehusmann, P., Adorjan, K., Antonucci, L. A., Blasi, G., Budde, M., et al. (2025) · medRxiv · doi:10.1101/2025.04.29.25326656 · Cited by 1
What's New Regarding Schizophrenia?
Thomas, S. P. (2014) · Issues in Mental Health Nursing · doi:10.3109/01612840.2014.938964
Nunes, P. P., Amorim, L. S., Delben, P. B., Gusso, H. L., & Cruz, R. M. (2018) · Revista Interdisciplinar de Estudos em Saúde · doi:10.33362/ries.v7i1.1553
Pachnik, C. (2018) · Białostockie Studia Prawnicze · doi:10.15290/bsp.2018.23.04.13
The impact of substance use on treatment as a compulsory patient
Vine, R., Tibble, H., Pirkis, J., Spittal, M. J., & Judd, F. K. (2019) · Australasian Psychiatry · doi:10.1177/1039856219852286
Cavichioli, A. M. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2022.tde-06052022-144555
Metabolic Profile of Patients with Schizophrenia
Khaustova, O. O. (2021) · Психиатрия психотерапия и клиническая психология · doi:10.34883/pi.2020.11.4.009
Thuan, N. T. M., Khoa, T. D., & Tuan, C. V. (2022) · Pharmaceutical Sciences Asia · doi:10.29090/psa.2022.04.22.063
Bhuiyan, P., Khan, M. A., Sun, Z., & Qian, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-2070137/v1
On the application of Machine Learning and Complex Networks to Neuroscience
Alves, C. L. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.55.2023.tde-31082023-145944
Services and systems of care for psychotic disorders: A global perspective
MALLA, A. K., & Iyer, S. N. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780198735588.003.0008
Moon, K. J., Stephenson, S., Hasenstab, K. A., Sridhar, S., Seiber, E. E., Breitborde, N. J. K., & Nawaz, S. (2023) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-023-09865-0
Kuo, E.-Y., Chern, J.-S., & Chu, C.-C. (2023) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc40787.2023.10341178
Relationship Between Schizophrenia and Sepsis : Evidence from two- sample mendelian randomizationPreprint
Liu, S., Mao, L., Chen, Y., & Deng, L. (2024) · Research Square · doi:10.21203/rs.3.rs-3829364/v1
Evolving Concepts for the Assessment and Treatment of Schizophrenia
Giordano, G. M., Pezzella, P., Gäebel, W., & Galderisi, S. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009067287.015
Self-citationKushnir, Y. A. (2023) · Likarska sprava · doi:10.31640/ls-2023-3-06
Liu, Y., Zhao, X., Long, Q., Guo, Z., Cao, X., Wu, X., Tu, F., Zhang, Y., Xu, Y., Shi, X., et al. (2024) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2024.102380
Metadata
- Authors
- Fleischhacker, W. W., Arango, C., Arteel, P., Barnes, T. R. E., Carpenter, W., Duckworth, K., Galderisi, S., Halpern, L., Knapp, M., Marder, S. R., Moller, M., Sartorius, N., & Woodruff, P.
- Affiliations
- Innsbruck Medical University (AT)
- Hospital General Universitario Gregorio Marañón (ES)
- Global Alliance of Mental Illness Advocacy Networks-Europe (BE)
- West London Mental Health NHS Trust (GB)
- University of Maryland, Baltimore (US)
- National Alliance on Mental Illness (US)
- University of Campania "Luigi Vanvitelli" (IT)
- King's College London (GB)
- Yale University (US)
- Royal College of Psychiatrists (GB)
- Corresponding author
- Fleischhacker, W. W.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-04-01
- Volume
- 40
- Issue
- Suppl 3
- Pages
- S165-S194
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- PMC
- PMC4002061
- OpenAlex
- W2153297237
- Cited by
- 214
- References
- 214
- Citations by year
- 2026: 6 · 2025: 21 · 2024: 31 · 2023: 26 · 2022: 24 · 2021: 31 · 2020: 21 · 2019: 15 · 2018: 11 · 2017: 13 · 2016: 10 · 2015: 2 · 2014: 3
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Schizophrenia Bulletin (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
- Health Sciences › Health Professions › General Health Professions › Mental Health and Patient Involvement
- Keywords
- schizophrenia, mental health policy
- MeSH terms
- Community Mental Health Services, Family Therapy, Health Policy, Humans, Patient Education as Topic, Psychotherapy, Quality of Life, Schizophrenia, Social Support, Antipsychotic Agents, Cognitive Behavioral Therapy, Employment, Supported, Evidence-Based Medicine, Recovery of Function, Independent Living
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review